Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Gefitinib MeSH Descriptor Data 2025


MeSH Heading
Gefitinib
Tree Number(s)
D03.633.100.786.469
Unique ID
D000077156
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077156
Scope Note
A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.
Entry Term(s)
Iressa
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide
ZD 1839
ZD1839
Pharm Action
Antineoplastic Agents
Tyrosine Kinase Inhibitors
Registry Numbers
S65743JHBS
0
Public MeSH Note
2019; GEFITINIB was indexed under QUINAZOLINES 2001-2018
History Note
2019 (2001)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2023/08/04
Gefitinib Preferred
ZD1839 Narrower
Iressa Narrower
page delivered in 0.15s